Visualant Wins Fourth Patent on ChromaID Technology Using Exclusive Spectral Pattern Matching Technique

Visualant Wins Fourth Patent on ChromaID Technology Using Exclusive Spectral
Pattern Matching Technique

SEATTLE, Nov. 1, 2012 (GLOBE NEWSWIRE) -- via PRWEB - Visualant, Inc.
(OTCBB:VSUL) – an industry-leading provider of chromatic-based identification
and diagnostic solutions, announced today that it received its fourth patent
on its ChromaID™ technology that uses an exclusive Spectral Pattern Matching™
("SPM") technique. The latest patent further validates the company's vision to
introduce more efficient security and authentication methods into the
marketplace, and comes shortly after Visualant and its investment partner
Sumitomo Precision Products Co., Ltd. ("SPP") showcased a prototype of its
Cyclops 6™ ChromaID hand-held scanner in Japan last month.

Future devices embedded with ChromaID technology can read and record natural
chromatic markers by structuring light onto a substance, through a liquid or
gas, or off a surface. Once scanned, the technology captures the reflected
light in a simple Photodiode and provides a unique ChromaID profile. The
ChromaID profile can be matched against existing databases to identify,
detect, or diagnosis markers invisible to the human eye.

Visualant Founder and CEO Ron Erickson believes ChromaID technology will usher
in new angles to protect consumer products, currencies, pharmaceuticals, and a
wide variety of products by bringing the power of spectral analysis from the
lab and into the field. Erickson states, "Our technology adds another
authentication layer to tools used by government and industrial entities who
grapple with the identification and security challenges that impact our
society at large."

ChromaID technology was developed in conjunction with renowned research
scientists, Drs. Tom Furness and Brian Schowengerdt. Together, they have
forged a unique proprietary approach to mapping color at the photon level and
using that mapping as a basis for authentication and diagnostics. In
conjunction with the stellar work being done in the lab, the company continues
to pursue an aggressive patent strategy to protect its unique intellectual

Drs. Furness and Schowengerdt and their laboratory development team brought a
generation of experience to the Visualant SPM development process. Dr. Furness
is known in many circles as the "Father of Virtual Reality." Dr. Schowengerdt
is an internationally renowned leader in the field of color perception.

The patent issued by the United States Office of Patents and Trademarks is US
Patent No. 8,285,510 B2 and is entitled "Method, Apparatus and Article To
Facilitate Distributed Evaluation of Object Using Electromagnetic Energy."

Ron Erickson, Visualant Founder and CEO, stated, "It's an honor to now hold
four patents covering our ChromaID technology. We expect more patents to be
issued as we build the intellectual property foundation for Visualant's
business and move into the marketplace with diverse applications of our SPM

About Visualant, Inc.

Visualant is a public company whose shares trade under the stock symbol, VSUL.
The Visualant Spectral Pattern Matching™ technology directs structured light
onto a substance, through a liquid/gas, or off a surface, to capture a unique
ChromaID. When matched against existing databases, a ChromaID™ can be used to
identify, detect, or diagnosis markers invisible to the human eye. ChromaID™
scanner modules can be integrated into a variety of mobile or fixed-mount form
factors. The patented technology is disruptive, making it possible to
effectively conduct analyses in the field that could only previously be
performed by large and expensive lab–based tests.

Visualant entered into a one year Joint Development Agreement on May 31, 2012
with Sumitomo Precision Products Co., Ltd. ("SPP"), which focuses on the
commercialization of the SPM technology and a License Agreement providing SPP
with an exclusive license of the SPM technology in identified Asian
territories. For more information, visit:

Sumitomo Precision Products Co., Ltd. is publicly traded on the Tokyo and
Osaka Stock Exchanges and has operations in Japan, United States, China,
United Kingdom, Canada, and other parts of the world. Additional information
on SPP is available at

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit

         Hal Bringman
         (323) 851-6877
Press spacebar to pause and continue. Press esc to stop.